Inhaled aerosolized insulin: A "topical" anti-inflammatory treatment for acute lung injury and respiratory distress syndrome?

Keyphrases

• Aerosolized 100%
• Insulin 100%
• Anti-inflammatory Therapy 100%
• Respiratory Distress Syndrome 100%
• Acute Lung Injury 100%
• Topical Anti-inflammatory 100%
• Acute Respiratory Distress Syndrome 40%
• Metabolic Effects 40%
• Inhalable 40%
• Insulin Resistance 20%
• Glucose Level 20%
• Hyperglycemia 20%
• Patient Management 20%
• NF-B 20%
• Sepsis 20%
• Systemic Inflammatory Response 20%
• Minimal Impact 20%
• Glucose Control 20%
• Glucose Concentration 20%
• Critically Ill 20%
• Inflammatory Factors 20%
• Pulmonary Function 20%
• Intravenous Administration 20%
• Insulin Therapy 20%
• Pulmonary Edema 20%
• Severe Acute Respiratory Distress Syndrome 20%
• Alveolar Inflammation 20%
• Insulin Formulations 20%
• Pulmonary Dysfunction 20%
• LPS Model 20%
• Pulmonary Injury 20%

Medicine and Dentistry

• Anti-Inflammatory Drug 100%
• Acute Lung Injury 100%
• Hyaline Membrane Disease 100%
• Acute Respiratory Distress Syndrome 60%
• Inhalable Insulin 40%
• Patient Care 20%
• Sepsis 20%
• Lung Function 20%
• Hyperglycemia 20%
• Insulin Treatment 20%
• Reactive Oxygen Species 20%
• Pulmonary Edema 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Anti-Inflammatory Drug 100%
• Acute Lung Injury 100%
• Hyaline Membrane Disease 100%
• Adult Respiratory Distress Syndrome 60%
• Inflammation 20%
• Lung Edema 20%
• Hyperglycemia 20%
• Sepsis 20%